Beyond The Numbers: 4 Analysts Discuss Ventas Stock
Benzinga Insights 8 months ago
Analyst Ratings
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Ventas (NYSE:VTR) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 3 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 1 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $86.5, a high estimate of $93.00, and a low estimate of $80.00. Witnessing a positive shift, the current average has risen by 9.15% from the previous average price target of $79.25.
Diving into Analyst Ratings: An In-Depth Exploration
An in-depth analysis of recent analyst actions unveils how financial experts perceive Ventas. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Richard Anderson | Cantor Fitzgerald | Maintains | Overweight | $93.00 | $93.00 |
| Todd M. Thomas | Keybanc | Raises | Overweight | $85.00 | $70.00 |
| John Kilichowski | Wells Fargo | Raises | Overweight | $88.00 | $80.00 |
| Nicholas Yulico | Scotiabank | Raises | Sector Perform | $80.00 | $74.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ventas. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ventas compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Ventas's stock. This comparison reveals trends in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Ventas's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Ventas analyst ratings.
Delving into Ventas's Background
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Unraveling the Financial Story of Ventas
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Positive Revenue Trend: Examining Ventas's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.17% as of 31 December, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: Ventas's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.48%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.56%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Ventas's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.26% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.06.
The Core of Analyst Ratings: What Every Investor Should Know
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.